• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.32% Nasdaq Down0.62%

    Enzon Pharmaceuticals Inc. (ENZN)

    -NasdaqCM
    0.51 Down 0.00(0.02%) Apr 29, 3:58PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 17,456   31,173   34,493  
    Cost of Revenue -   -   -  
    Gross Profit 17,456   31,173   34,493  
    Operating Expenses
    Research Development -   -  2,715  
    Selling General and Administrative6,656  2,383  8,843  
    Non Recurring -   -  4,776  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 10,800   28,790   18,159  
    Income from Continuing Operations
    Total Other Income/Expenses Net -  61  2,087  
    Earnings Before Interest And Taxes10,800  28,851  20,246  
    Interest Expense -   -  2,124  
    Income Before Tax10,800  28,851  18,122  
    Income Tax Expense(10,837)56  (28)
    Minority Interest -   -   -  
    Net Income From Continuing Ops21,637  28,795  18,150  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 21,637   28,795   18,150  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 21,637   28,795   18,150  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.